AAAAAA
Results: 1-25/34
Authors:
Hidalgo, M
Eckhardt, SG
Citation: M. Hidalgo et Sg. Eckhardt, Development of matrix metalloproteinase inhibitors in cancer therapy, J NAT CANC, 93(3), 2001, pp. 178-193
Authors:
Sanchez, JM
Hidalgo, M
Salvado, V
Citation: Jm. Sanchez et al., Synthesised phosphine sulphide-type macroporous polymers for the preconcentration and separation of gold (III) and palladium (II) in a column system, REACT FUNCT, 49(3), 2001, pp. 215-224
Authors:
Sanchez, JM
Hidalgo, M
Salvado, V
Citation: Jm. Sanchez et al., The selective adsorption of gold (III) and palladium (II) on new phosphinesulphide-type chelating polymers bearing different spacer arms - Equilibrium and kinetic characterisation, REACT FUNCT, 46(3), 2001, pp. 283-291
Authors:
Hidalgo, M
Eckhardt, SG
Citation: M. Hidalgo et Sg. Eckhardt, Matrix metalloproteinase inhibitors: How can we optimize their development?, ANN ONCOL, 12(3), 2001, pp. 285-287
Authors:
Fontas, C
Compano, L
Polo, A
Salvado, V
Hidalgo, M
Citation: C. Fontas et al., Benzyl(2-methoxy-3-diphenylphosphino)propyl ether as a carrier for the selective transport of Pd(II) through a solid supported liquid membrane, SOLVENT EXT, 19(2), 2001, pp. 329-344
Authors:
Hidalgo, M
Aylesworth, C
Hammond, LA
Britten, CD
Weiss, G
Stephenson, J
Schwartz, G
Patnaik, A
Smith, L
Molpus, K
Felton, S
Gupta, E
Ferrante, KJ
Tortora, A
Sonnichsen, DS
Skillings, J
Rowinsky, EK
Citation: M. Hidalgo et al., Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel, J CL ONCOL, 19(9), 2001, pp. 2493-2503
Authors:
Hidalgo, M
Siu, LL
Nemunaitis, J
Rizzo, J
Hammond, LA
Takimoto, C
Eckhardt, SG
Tolcher, A
Britten, CD
Denis, L
Ferrante, K
Von Hoff, DD
Silberman, S
Rowinsky, EK
Citation: M. Hidalgo et al., Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies, J CL ONCOL, 19(13), 2001, pp. 3267-3279
Authors:
Tolcher, AW
Eckhardt, SG
Kuhn, J
Hammond, L
Weiss, G
Rizzo, J
Aylesworth, C
Hidalgo, M
Patnaik, A
Schwartz, G
Felton, S
Campbell, E
Rowinsky, EK
Citation: Aw. Tolcher et al., Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties, J CL ONCOL, 19(11), 2001, pp. 2937-2947
Authors:
Hidalgo, M
Rowinsky, EK
Citation: M. Hidalgo et Ek. Rowinsky, The rapamycin-sensitive signal transduction pathway as a target for cancertherapy, ONCOGENE, 19(56), 2000, pp. 6680-6686
Authors:
Sanchez, JM
Hidalgo, M
Valiente, M
Salvado, V
Citation: Jm. Sanchez et al., New macroporous polymers for the selective adsorption of gold (III) and palladium (II). I. The synthesis, characterization, and effect of spacers on metal adsorption, J POL SC PC, 38(2), 2000, pp. 269-278
Authors:
Sanchez, JM
Hidalgo, M
Salvado, V
Citation: Jm. Sanchez et al., The separation of Au(III) and Pd(II) in hydrochloric acid solutions by strong anion type II exchange resins: The effect of counter ion concentration and temperature, SOLVENT EXT, 18(6), 2000, pp. 1199-1217
Authors:
Eckhardt, SG
Baker, SD
Britten, CD
Hidalgo, M
Siu, L
Hammond, LA
Villalona-Calero, MA
Felton, S
Drengler, R
Kuhn, JG
Clark, GM
Smith, SL
MacDonald, JR
Smith, C
Moczygemba, J
Weitman, S
Von Hoff, DD
Rowinsky, EK
Citation: Sg. Eckhardt et al., Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies, J CL ONCOL, 18(24), 2000, pp. 4086-4097
Authors:
Patnaik, A
Rowinsky, EK
Tammara, BK
Hidalgo, M
Drengler, RL
Garner, AM
Siu, LL
Hammond, LA
Felton, SA
Mallikaarjun, S
Von Hoff, DD
Eckhardt, SG
Citation: A. Patnaik et al., Phase I and pharmacokinetic study of the differentiating agent vesnarinonein combination with gemcitabine in patients with advanced cancer, J CL ONCOL, 18(23), 2000, pp. 3974-3985
Authors:
Gomez-Martin, C
Sola, C
Hornedo, J
Perea, S
Lumbreras, C
Valenti, V
Arcediano, A
Rodriguez, M
Salazar, R
Cortes-Funes, H
Hidalgo, M
Citation: C. Gomez-martin et al., Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: Results of a randomized clinical trial, J CL ONCOL, 18(10), 2000, pp. 2126-2134
Authors:
Hidalgo, M
Villalona-Calero, MA
Eckhardt, SG
Drengler, RL
Rodriguez, G
Hammond, LA
Diab, SG
Weiss, G
Garner, AM
Campbell, E
Davidson, K
Louie, A
O'Neil, JD
von Borstel, R
Von Hoff, DD
Rowinsky, EK
Citation: M. Hidalgo et al., Phase I and pharmacologic study of PN401 and fluorouracil in patients withadvanced solid malignancies, J CL ONCOL, 18(1), 2000, pp. 167-177
Authors:
Rowinsky, EK
Humphrey, R
Hammond, LA
Aylesworth, C
Smetzer, L
Hidalgo, M
Morrow, M
Smith, L
Garner, A
Sorensen, JM
Von Hoff, DD
Eckhardt, SG
Citation: Ek. Rowinsky et al., Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patientswith solid malignancies, J CL ONCOL, 18(1), 2000, pp. 178-186
Authors:
Fontas, C
Palet, C
Salvado, V
Hidalgo, M
Citation: C. Fontas et al., A hollow fiber supported liquid membrane based on Aliquat 336 as a carrierfor rhodium(III) transport and preconcentration, J MEMBR SCI, 178(1-2), 2000, pp. 131-139
Authors:
Pena, JR
Hidalgo, M
Mijangos, C
Citation: Jr. Pena et al., Plastification of poly(vinyl chloride) by polymer blending, J APPL POLY, 75(10), 2000, pp. 1303-1312
Authors:
Sanchez, JM
Hidalgo, M
Valiente, M
Salvado, V
Citation: Jm. Sanchez et al., Simplex optimisation of a flow injection analysis (FIA) system to determine rare earth elements (REE) with Arsenazo III, ANAL LETTER, 33(3), 2000, pp. 553-569
Authors:
Hidalgo, M
Izbicka, E
Eckhardt, SG
MacDonald, JR
Cerna, C
Gomez, L
Rowinsky, EK
Weitman, SD
Von Hoff, DD
Citation: M. Hidalgo et al., Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units, ANTI-CANC D, 10(9), 1999, pp. 837-844
Authors:
Hidalgo, M
Rinaldi, D
Medina, G
Griffin, T
Turner, J
Von Hoff, DD
Citation: M. Hidalgo et al., A phase I trial of topical topitriol (calcitriol, 1,25-dihydroxyvitamin D-3) to prevent chemotherapy-induced alopecia, ANTI-CANC D, 10(4), 1999, pp. 393-395
Authors:
Hidalgo, M
Izbicka, E
Cerna, C
Gomez, L
Rowinsky, EK
Weitman, SD
Von Hoff, DD
Citation: M. Hidalgo et al., Comparative activity of the cyclopropylpyrroloindole compounds adozelesin,bizelesin and carzelesin in a human tumor colony-forming assay, ANTI-CANC D, 10(3), 1999, pp. 295-302
Authors:
Sanchez, JM
Hidalgo, M
Salvado, V
Valiente, M
Citation: Jm. Sanchez et al., Extraction of neodymium(III) at trace level with di(2-ethyl-hexyl)phosphoric acid in hexane, SOLVENT EXT, 17(3), 1999, pp. 455-474
Authors:
Fontas, C
Salvado, V
Hidalgo, M
Citation: C. Fontas et al., Solvent extraction of Pt(IV) by Aliquat 336 and its application to a solidsupported liquid membrane system, SOLVENT EXT, 17(1), 1999, pp. 149-162
Authors:
Hidalgo, M
Castellano, D
Paz-Ares, L
Gravalos, C
Diaz-Puente, M
Hitt, R
Alonso, S
Cortes-Funes, H
Citation: M. Hidalgo et al., Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer, J CL ONCOL, 17(2), 1999, pp. 585-592